Back to search
Heart Failure With Reduced Ejection Fraction (HFrEF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure With Reduced Ejection Fraction (HFrEF) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure With Reduced Ejection Fraction (HFrEF) trials you may qualify forDigiCare-HFrEF is an investigator-initiated, multicentre, randomised, open-label, endpoint-blinded, superiority trial designed to evaluate whether a structured…
This is an observational study in which only data are collected from participants receiving their usual treatment. The study is done in people with chronic hear…
This is a single-center, randomized, open-label, no-profit interventional trial designed to evaluate the effectiveness of a telemedicine-based follow-up strateg…
Heart failure (HF) is a global public health issue that affects more than 63 million people worldwide. The clinical and economic burden of HF on health care sys…
This randomized, controlled, open-label, parallel, multicenter clinical study evaluates the efficacy of SmartSignalHF compared with heart failure (HF) remote mo…
The goal of this clinical trial is to measure the effectiveness of video monitoring associated with the transition of care for patients with heart failure. The…
This retrospective study will take advantage of an existing EU-funded dataset, the BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF), w…
This is a randomized, double-blind, placebo-controlled two-part study with a multiple escalating dose phase followed by a cohort expansion phase to assess safet…
Primary Outcome: Composite of cardiovascular death or recurrent heart failure hospitalization over study duration Secondary Outcomes: Cardiovascular death ov…